Inside Standards

Latest News

December 22nd 2022

Highlights of December 2022 EMA Management Board Meeting

In addition, the Clinical Trials Regulation is set to become a single-entry point for sponsors and regulators in January 2023 for the submission and assessment of all new clinical trials.

May 26th 2020

FDA Leadership Shifts to Advance COVID-19 Treatments

By Jill Wechsler

June 1st 2015

What’s In a Name? For Biosimilars, A Lot

By Randi Hernandez

May 2nd 2015

Ensuring the Quality of Biologicals

May 1st 2015

An Update on the Quality Metrics Initiative

USP Publishes Monoclonal Antibody Guidelines

March 2nd 2015

A General Chapter on mAbs will be published in USP-NF as biologics increase their role in healthcare.

Tools of the Trade for Preventing Drug Shortages

March 1st 2015

A new technical report guides bio/pharma companies in establishing a risk-based approach for prevention and management of drug shortages.

Standards Organizations Update

BySusan Haigney

January 1st 2015

In late 2014, standards organizations continued to work towards harmonization and securing drug safety.

Inside Standards

Latest News

USP Publishes Monoclonal Antibody Guidelines

Tools of the Trade for Preventing Drug Shortages

Standards Organizations Update

Trending on BioPharm International

Strategic Shifts for Speed, Resilience, and Long-Term Sustainability in Biomanufacturing

Advances in Continuous Manufacturing, Drug Delivery Lead CPHI Pharma Awards 2025

EU Biopharma Strategy: Scaling Up to Tackle Funding Gaps and Drive Innovation

Why Data Quality, Not Regulation, Is the True Barrier to AI in Biologics

Achieving Real Impact Navigating the Data and Regulatory Barriers to AI Adoption in Bio/pharma